We recently published a list of the 13 Best High Volume Stocks to Buy Now. In this article, we are going to take a look at ...

Evaluate AbbVie Inc. vs. Pfizer Inc. amidst tariff disputes and drug pricing policies. Click for our comparison of ABBV and ...

Pfizer's 7.45% dividend yield can't offset weak growth, declining EPS, and patent risks. Read more on PFE and why analysts ...

We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are ...

Pfizer (NYSE:PFE) is one of the world’s largest pharmaceutical companies, but at $22.59 per share as of this writing, the ...

Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...

We recently published a list of the 15 Best High-Yield Dividend Stocks for 2025 and Beyond. In this article, we are going to ...

Shares of UnitedHealth Group (NYSE:UNH) are down more than 7% in premarket trading on Thursday after it was reported that the U.S. Department of Justice is conducting a criminal investigation into the ...

Below is Validea's guru fundamental report for PFIZER INC (PFE). Of the 22 guru strategies we follow, PFE rates highest using our Shareholder Yield Investor model based on the published strategy ...

The executive order that Donald Trump has signed over the last 24 hours could have a significant effect on pharmaceutical ...

From a technical perspective, Pfizer (PFE) is looking like an interesting pick, as it just reached a key level of support. PFE recently overtook the 20-day moving average, and this suggests a ...